반응식
[Br:1][C:2]1[C:3]([Cl:11])=[N:4][CH:5]=[C:6]([CH:10]=1)[C:7]([OH:9])=O.[Cl:12][C:13]([F:23])([F:22])[S:14][C:15]1[CH:21]=[CH:20][C:18]([NH2:19])=[CH:17][CH:16]=1>>[Br:1][C:2]1[C:3]([Cl:11])=[N:4][CH:5]=[C:6]([CH:10]=1)[C:7]([NH:19][C:18]1[CH:20]=[CH:21][C:15]([S:14][C:13]([Cl:12])([F:22])[F:23])=[CH:16][CH:17]=1)=[O:9]참가 물질
3
실험 절차
The title compound was prepared in an analogous fashion to that described in Stage 11.2 using 5-bromo-6-chloro-nicotinic acid and 4-((chloro-difluoromethyl)thio)aniline (Stage 18.3) to afford an off-white crystalline solid. HPLC (Condition 4) tR=6.78 min, UPLC-MS (Condition 3) tR=1.32 min, m/z=425 [M−H]−.
후처리
- customto afford an off-white crystalline solid
출처 및 근거
- ORD 기록
- ord-2e20c9ebd32648309d5f92851d6f7241
- 출처 데이터셋
- uspto-grants-2014_09
- 특허 번호
- US08829195B2
연결된 노트
불러오는 중…